Acne treatments often target the biological processes that occur deep within the hair follicle, where many acne lesions begin forming long before they become visible on the skin. Inside each follicle, sebaceous glands produce sebum while skin cells lining the pore shed continuously. In acne-prone skin, these cells may stick together and combine with excess oil, creating microscopic blockages known as microcomedones. These early lesions can exist beneath the surface for weeks before developing into visible blackheads, whiteheads, or inflamed acne lesions. Because acne treatments work by influencing these underlying processes, the skin may appear to worsen temporarily as existing microcomedones move toward the surface.
One of the most common reasons for this temporary worsening is the effect of treatments that accelerate skin cell turnover. Retinoids, which are widely used in dermatology, help normalize the shedding of skin cells within the follicle and prevent new blockages from forming. As this process begins, previously hidden microcomedones may surface more quickly than they would have naturally. This can lead to an increase in visible breakouts during the early weeks of treatment, even though the medication is actively addressing the underlying causes of pore blockage.
Other commonly used ingredients may contribute to similar temporary changes. Benzoyl peroxide works by reducing populations of acne-associated bacteria and limiting inflammation within the follicle. Salicylic acid helps dissolve oil and debris that accumulate inside pores. As these ingredients begin clearing the follicular canal, existing clogged pores may open and become visible before the skin begins to stabilize. This phase can sometimes create the impression that acne is worsening, even though the treatment is gradually improving the internal environment of the follicle.
Inflammation may also temporarily increase during the early stages of treatment. When clogged pores begin clearing and follicular contents shift, the surrounding skin may respond with mild irritation or redness. In some cases, the skin barrier may require time to adapt to active ingredients, especially if treatments are introduced too quickly or used in high concentrations. Gentle moisturizers and gradual introduction of active ingredients are often recommended to help support the skin barrier during this adjustment period.
The timeline of the skin’s natural renewal cycle also contributes to delayed improvement. The formation of acne lesions can begin several weeks before they become visible, meaning that breakouts appearing during early treatment may have already been developing before the skincare routine started. Because treatments primarily prevent new blockages and regulate follicular activity, noticeable improvement usually occurs only after these earlier lesions have resolved.
For many individuals, this adjustment phase is temporary and typically improves after several weeks of consistent treatment. Dermatology guidelines often suggest allowing six to twelve weeks to evaluate the effectiveness of acne therapies, as this timeframe aligns more closely with the biological processes involved in follicular turnover and sebum regulation. Abruptly stopping treatments during the early phase may interrupt these processes before the skin has time to stabilize.
Although temporary worsening can occur, it does not happen in every case and may vary depending on the type of acne, the ingredients used, and individual skin sensitivity. If irritation becomes severe or acne continues worsening for an extended period, consultation with a qualified dermatologist may help determine whether adjustments to the treatment plan are needed. With consistent use and appropriate guidance, many acne treatments gradually reduce clogged pores and inflammation, leading to clearer skin over time.
